Bionano Genomics, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -23.37M-18.50M-29.82M-41.11M-72.44M-132.60M-232.49M-112.02M
Depreciation and Depletion 1.13M1.40M1.90M3.80M6.50M4.90M
Share-based Compensation 0.38M1.19M1.35M1.55M9.72M22.42M15.18M9.74M
Deferred Taxes -5.78M1.76M
Gains from Investment Securities -0.75M-3.99M4.75M0.52M-1.46M-10.90M
Asset Writedowns and Impairment 0.60M1.29M0.55M1.81M0.65M7.23M
Cash from Operations -20.82M-19.94M-29.53M-38.31M-71.93M-124.82M-125.18M-68.92M
Depreciation, Depletion & Amortization
Amortization of Goodwill 77.30M
Amortizatization of Intangibles 0.33M-0.64M0.54M1.32M
Depreciation & Amortization (CF) 1.50M1.32M1.13M1.48M3.35M9.62M13.71M14.02M
Change in Working Capital
Change in Receivables 1.77M0.90M2.37M-2.09M0.49M2.25M2.30M-4.14M
Change in Inventory 0.34M0.42M3.64M4.20M15.93M23.68M4.15M0.59M
Change in Account Payables 1.54M-0.95M1.36M-1.81M6.78M1.95M-2.00M-3.42M
Change in Accured Expenses -0.12M-0.25M-0.07M1.48M3.96M0.37M-2.52M-1.99M
Other Working Capital Changes -0.77M-0.15M0.25M1.00M1.32M3.20M5.02M-4.68M
Investing Activities
Capital Expenditures 1.02M0.33M0.06M0.64M2.41M1.69M0.10M
Sales of Property, Plant and Equipment 0.03M
Change in Intangibles 0.10M
Acquisitions 2.45M49.09M31.34M
Change in Acquisitions & Divestments 86.48M200.89M137.02M306.96M
Cash from Investing Activities -1.02M-0.33M-0.06M-2.45M-278.06M82.77M24.16M73.84M
Financing Activities
Other financing activities 2.00M1.70M0.58M4.52M2.95M
Cash from Financing Activities 17.61M35.78M30.38M61.90M336.11M23.01M113.81M-13.69M
Additional items
Exchange Rate Effect -0.04M0.07M-0.01M
Change in Cash -4.23M15.50M0.79M21.14M-13.88M-19.08M12.86M-8.78M
Beginning Cash Balance 5.25M1.02M16.52M17.31M38.45M24.17M5.09M17.95M
Free Cash Flow -21.84M-20.28M-29.59M-38.31M-72.56M-127.22M-126.87M-69.03M
Net Cash Flow -4.23M15.50M0.79M21.14M-13.88M-19.04M12.79M-8.77M